Cofactor Genomics - Leveraging RNA and Machine Learning to Bridge the Precision Medicine Gap

July 16, 2020

Cofactor Genomics is using machine learning and RNA sequencing to build multidimensional biomarkers that can accurately stratify patients as responders or non-responders to different therapies. Bridging this gap in immune-oncology alone would save US healthcare billions in annual costs and deliver on this promise of more precise healthcare for patients.

 

Presented by Natalie LaFranzo, VP Market Development / Cofactor Genomics

Previous Video
MetroPlus Health - Reaching the Most Vulnerable: Covid Crisis Management Through Technology
MetroPlus Health - Reaching the Most Vulnerable: Covid Crisis Management Through Technology

Presented by Amanda Parsons, MD, MBA, Deputy, Chief Medical Officer MetroPlus Health Plan / MetroPlusHealth

Next Video
Change Healthcare - Innovating Go-To-Market Approaches for Healthcare with AWS Marketplace
Change Healthcare - Innovating Go-To-Market Approaches for Healthcare with AWS Marketplace

Presented by Gautam Shah, “G”, VP Platform and Marketplace / Change Healthcare